Current Treatment Options in Cardiovascular Medicine 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Impact of COVID-19 on Arrhythmia Care Delivery
AbstractPurpose of reviewThe goal of this review is to provide the reader with an overview of how the coronavirus disease 2019 (COVID-19) pandemic affected the management of arrhythmias.Recent findingsMany aspects of electrophysiology (EP) care required augmentation during the COVID-19 pandemic. Despite this, EP physicians were often reallocated to the care of non-EP patients due to limitations in hospital staffing and increased hospitalizations. To limit viral exposure for clinicians and patients, various changes were implemented, including an increased reliance on telehealth and other remote technologies for outpatient m...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
Nonstructural Genetic Cardiac Disease as the Most Common Cause of Sudden Cardiac Death in the Young Athlete: Is This True?
AbstractPurpose of reviewThis review is aimed at summarizing and discussing the primary causes of sudden cardiac death (SCD) in young athletes.Recent findingsSCD in young athletes is a dramatic event, with an incidence rate that can reach 13 deaths per 100,000 athletes. Occasionally, exercise can trigger SCD, and unfortunately, this event may be the first manifestation of an underlying and silent cardiac condition. In the USA, hypertrophic cardiomyopathy is reported as the leading cause of SCD among young athletes, whereas arrhythmogenic right ventricular cardiomyopathy has been reported as the main cause in the Veneto r...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
State-of-the-Art Review: Alcohol Septal Ablation in Hypertrophic Cardiomyopathy
The objective of this review is to provide the reader with a synopsis of percutaneous alcohol septal ablation (ASA) as an effective and time-honored treatment modality in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM).Recent findingsPatients who have medically refractory symptoms of dynamic left ventricular outflow tract obstruction may benefit from septal reduction therapy including septal myectomy or ASA. ASA involves infusion of alcohol into an epicardial septal artery supplying the basal septum to generate an iatrogenic infarction and, thus, reduce outflow tract obstruction due to targeted hypo...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
Is Early Repolarization Syndrome a Risk for Sudden Cardiac Death in Young Athletes?
AbstractPurpose of reviewTo review data available in medical literature on the prognostic implications of the detection of an “early repolarization” (ER) pattern at standard electrocardiogram (ECG) in athletes, with particular reference to a possible increased risk of sudden death.Recent findingsIn 2010, a case –control study of patients with vs. without idiopathic ventricular fibrillation in athletes found a higher prevalence of infero-lateral slurring J wave in cases than controls (28.6% vs. 7.6%;p = 0.006). Subsequently, a few studies assessed the prognostic value of the ER pattern (J point/ST-segment elevatio...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
Persistent Atrial Fibrillation Ablation: Ongoing Challenges Defining the Target Population and Substrate
AbstractPurpose of ReviewCatheter ablation (CA) is a well-established treatment for paroxysmal atrial fibrillation (AF), but outcomes in persistent AF can be suboptimal. This review summarises recent evidence relating to the ideal patient population and target substrate for CA, and the techniques available.Recent FindingsRisk scores can identify individuals with persistent AF who are more likely to benefit from CA. Pulmonary vein isolation (PVI) remains the most important ablation technique but non-pulmonary vein triggers explain the high recurrence rates in persistent AF. Novel electroanatomic mapping technologies, hybrid...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
COVID-19 Vaccine –Associated Myocarditis Considerations for Competitive Athletes
AbstractPurpose of reviewTo review the epidemiology of COVID-19 vaccine –associated myocarditis (VAM), evaluation of athletes with suspected VAM, and safe return to play for athletes with confirmed VAM.Recent findingsVAM is a rare complication of COVID-19 vaccination, with pretest probability highest in those who experience chest pain within several days after messenger RNA vaccine administration. While data from young athletes with VAM are lacking, the initial evaluation for those with high pre-test probability of VAM includes ECG, echocardiography, and troponin testing. Those with abnormal testing warrant cardiac mag...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
Artificial Intelligence and Machine Learning in Electrophysiology —a Short Review
AbstractPurpose of reviewTo summarize the expanding role of artificial intelligence (AI) in cardiac electrophysiology.Recent findingsAI is uniquely powered to integrate variable data-streams and consider complex non-linear relationships. Deep learning algorithms can consider aspects in data with unappreciated relevance in order to produce results that are impossible with other methods.The wide adoption of wearable technologies necessitated the development of accurate algorithms to identify cardiac rhythms. Similarly, algorithms use electrocardiograms to make arrhythmic diagnosis, localize arrhythmias, and uncover pathologi...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
The Role of Supervised Exercise Therapy in the Management of Symptomatic Peripheral Artery Disease with Intermittent Claudication
AbstractPurpose of reviewThis review highlights the latest progress and future directions for the role of supervised exercise therapy (SET) in the management of symptomatic peripheral artery disease (PAD) with intermittent claudication (IC).Recent findingsSET is a cornerstone therapy to improve walking distance and functional status in symptomatic PAD patients with IC, but the low participation rate is a long-standing challenge. Recently, some pioneer studies have integrated SET into home-based exercise intervention (HBEI) with new technologies and clinical practice. For home-based walking exercise, the LITE trial report...
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
Correction to: An Evidence ‑Based Update on Physiological Pacing
(Source: Current Treatment Options in Cardiovascular Medicine)
Source: Current Treatment Options in Cardiovascular Medicine - October 1, 2023 Category: Cardiology Source Type: research
Guidelines in Cardio-Oncology: The Balance Between Evidence and Expert Opinion
AbstractPurpose of reviewWhile expert opinion is an important tool in the development of clinical practice guidelines (CPGs), it must be used judiciously and balanced with the available evidence. In this review, we carefully examine the role of balancing evidence and expert opinion in the context of the 2022 European Society of Cardiology (ESC) Cardio-Oncology guidelines, including the factors that influence the weight given to expert opinion and potential impact on health care systems adhering to specific guideline recommendations.Recent findingsIn an attempt to be all-encompassing, the 2022 ESC guidelines risk diluting i...
Source: Current Treatment Options in Cardiovascular Medicine - September 28, 2023 Category: Cardiology Source Type: research
Correction to: An Evidence ‑Based Update on Physiological Pacing
(Source: Current Treatment Options in Cardiovascular Medicine)
Source: Current Treatment Options in Cardiovascular Medicine - September 28, 2023 Category: Cardiology Source Type: research
Exercise and Sports Participation in Children with Cardiomyopathy: A Review
AbstractPurpose of reviewThere are numerous health benefits to exercise, including improved cardiovascular, metabolic, and mental health. Despite these many benefits, children with cardiomyopathy have been traditionally restricted from engaging in exercise or participating in organized sports. The purpose of this review is to summarize the current literature regarding the utility of cardiopulmonary exercise testing, discuss the safety and benefits of exercise and sports participation in children with cardiomyopathy, and to identify research gaps in the field.Recent findingsWe highlight relevant literature discussing exerci...
Source: Current Treatment Options in Cardiovascular Medicine - September 15, 2023 Category: Cardiology Source Type: research
Persistent Atrial Fibrillation Ablation: Ongoing Challenges Defining the Target Population and Substrate
AbstractPurpose of ReviewCatheter ablation (CA) is a well-established treatment for paroxysmal atrial fibrillation (AF), but outcomes in persistent AF can be suboptimal. This review summarises recent evidence relating to the ideal patient population and target substrate for CA, and the techniques available.Recent FindingsRisk scores can identify individuals with persistent AF who are more likely to benefit from CA. Pulmonary vein isolation (PVI) remains the most important ablation technique but non-pulmonary vein triggers explain the high recurrence rates in persistent AF. Novel electroanatomic mapping technologies, hybrid...
Source: Current Treatment Options in Cardiovascular Medicine - September 15, 2023 Category: Cardiology Source Type: research
Valvular Heart Disease and Pregnancy: An Update
AbstractPurpose of the reviewTo provide a comprehensive overview of the current state of knowledge and recent advances in the management of valvular heart disease (VHD) in pregnancy.Recent findingsThe management of VHD in pregnancy spans from preconception evaluation with a multidisciplinary pregnancy heart team through pregnancy and the post-partum. Catheter-based valvular interventions have emerged as a potential treatment option during pregnancy for women refractory to conservative management. Recent research suggests that women with regurgitant valvular lesions are also at risk of pregnancy complications, bringing to q...
Source: Current Treatment Options in Cardiovascular Medicine - September 14, 2023 Category: Cardiology Source Type: research
